Goldman Sachs analyst Brooke Roach lowered the firm’s price target on Canada Goose (GOOS) to $34 from $46 and keeps a Sell rating on the shares. Canada Goose reported healthy Q3 revenue growth with positive global DTC comps and broad-based momentum across major regions, supported by product newness and expanded assortments, but EBIT fell short due to a one-time bad debt charge and prior-year FX gains, and SG&A remained elevated, leaving the path to sustainable margin expansion and operating leverage uncertain, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOOS:
- Canada Goose price target lowered to $12 from $14 at UBS
- Canada Goose price target lowered to C$12 from C$14 at Williams Trading
- Canada Goose downgraded to Neutral from Outperform at Baird
- Canada Goose downgraded to Underweight from Equal Weight at Barclays
- Canada Goose Stock (GOOS) Crashes 20% After Big Earnings Miss
